Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 5, 2007, Pages 464-469

  Intorre, L ^a   Vanni, M ^a   Di Bello, D ^a   Pretti, C ^a   Meucci, V ^a   Tognetti, R ^a   Soldani, G ^a   Cardini, G ^a   Jousson, O ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF TRENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DANOFLOXACIN; DIFLOXACIN; ENOXACIN; ENROFLOXACIN; FLUMEQUINE; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MARBOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; ORBIFLOXACIN; PEFLOXACIN; QUINOLONE DERIVATIVE; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA GYRASE; DNA PRIMERS; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS INTERMEDIUS; STAPHYLOCOCCUS SCHLEIFERI;

EID: 34548460230     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00896.x     Document Type: Article

References (47)

1. Ba, B.B., Arpin, C., Vidaillac, C., Chausse, A., Saux, M.C. Quentin, C. (2006) Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrobial Agents and Chemotherapy, 50, 1931 1936.
2. Barragry, T.B. (eds 1994) Pyodermas and flea infestations. In Veterinary Drug Therapy. pp. 855 878. Lea & Febiger, Philadelphia.
3. Becker, K., Harmsen, D., Mellmann, A., Meier, C., Schumann, P., Peters, G. von Eiff, C. (2004) Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. Journal of Clinical Microbiology, 42, 4988 4995.
4. Biberstein, E.L., Jang, S.S. Hirsh, D.C. (1984) Species distribution of coagulase-positive staphylococci in animals. Journal of Clinical Microbiology, 19, 610 615.
5. Blondeau, J.M. (2004) Fluoroquinolones: mechanism of action, classification, and development of resistance. Survey of Ophthalmology, 49, S73 S78.
6. CA-SFM (2006) Comité de l'Antibiogramme de la Socié té Française de Microbiologie. Communiqué 2006. http://www.sfm.asso.fr/nouv/general.php?pa=5.
7. CLSI (2007) Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute; CLSI M100-S17, Wayne, PA, USA.
8. Dubin, D.T., Fitzgibbon, J.E., Nahvi, M.D. John, J.F. (1999) Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrobial Agents and Chemotherapy, 43, 1631 1637.
9. van Duijkeren, E., Wolfhagen, M.J., Box, A.T., Heck, M.E., Wannet, W.J. Fluit, A.C. (2004) Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerging Infectious Diseases, 10, 2235 2237.
10. Euzeby, J.P. (1997) List of bacterial names with standing in nomenclature: a folder available on the Internet. International Journal of Systematic Bacteriology, 47, 590 592.
11. Fitzgibbon, J.E., John, J.F., Delucia, J.L. Dubin, D.T. (1998) Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 42, 2122 2124.
12. Frank, L.A., Kania, S.A., Hnilica, K.A., Wilkes, R.P. Bemis, D.A. (2003) Isolation of Staphylococcus schleiferi from dogs with pyoderma. Journal of the American Veterinary Medical Association, 15, 451 454.
13. Futagawa-Saito, K., Ba-Thein, W., Sakurai, N. Fukuyasu, T. (2006) Prevalence of virulence factors in Staphylococcus intermedius isolates from dogs and pigeons. BMC Veterinary Research, 26, 1 5.
14. Hajek, V. (1976) Staphylococcus intermedius, a new species isolated from animals. International Journal of Systematic Bacteriology, 26, 401 408.
15. Hall, T.A. (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series, 41, 95 98.
16. Harmsen, D., Rothgänger, J., Frosch, M. Albert, J. (2002) RIDOM: ribosomal differentiation of medical micro-organisms database. Nucleic Acids Research, 30, 416 417.
17. Hartmann, F.A., White, D.G., West, S.E., Walker, R.D. Deboer, D.J. (2005) Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma. Veterinary Microbiology, 108, 119 131.
18. Heinen, E. (2002) Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics, 25, 1 5.
19. Hoekstra, K.A. Paulton, R.J. (2002) Clinical prevalence and antimicrobial susceptibility of Staphylococcus aureus and Staph. intermedius in dogs. Journal of Applied Microbiology, 93, 406 413.
20. Hooper, D.C. (1999) Mechanisms of fluoroquinolone resistance. Drug Resistance Updates, 2, 38 55.
21. Hooper, D.C. (2001) Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clinical Infectious Diseases, 32, S9 S15. H.
22. Hooper, D.C. (2002) Fluoroquinolone resistance among Gram-positive cocci. Lancet Infectious Diseases, 2, 530 538.
23. Horspool, L.J., van Laar, P., van den Bos, R. Mawhinney, I. (2004) Treatment of canine pyoderma with ibafloxacin and marbofloxacin-fluoroquinolones with different pharmacokinetic profiles. Journal of Veterinary Pharmacology and Therapeutics, 27, 147 153.
24. Jacoby, G.A. (2005) Mechanisms of resistance to quinolones. Clinical Infectious Diseases, 41, S120 S126.
25. Kania, S.A., Williamson, N.L., Frank, L.A., Wilkes, R.P., Jones, R.D. Bemis, D.A. (2004) Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma. American Journal of Veterinary Research, 65, 1265 1268.
26. Linde, H.J., Schmidt, M., Fuchs, E., Reischl, U., Niller, H.H. Lehn, N. (2001) In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrobial Agents and Chemotherapy, 45, 1553 1557.
27. Lloyd, D.H., Lamport, A.I., Noble, W.C. Howell, S.A. (1999) Fluoroquinolone resistance in Staphylococcus intermedius. Veterinary Dermatology, 10, 249 251.
28. Lu, T., Zhao, X. Drlica, K. (1999) Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group. Antimicrobial Agents and Chemotherapy, 43, 2969 2974.
29. May, E.R., Hnilica, K.A., Frank, L.A., Jones, R.D. Bemis, D.A. (2005) Isolation of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma, or both. Journal of the American Veterinary Medical Association, 227, 928 931.
30. Morris, D.O., Rook, K.A., Shofer, F.S. Rankin, S.C. (2006) Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04). Veterinary Dermatology, 17, 332 337.
31. Nagai, K., Davies, T.A., Pankuch, G.A., Dewasse, B.E., Jacobs, M.R. Appelbaum, P.C. (2000) In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 44, 2740 2746.
32. NCCLS (1990) Performance Standards for Antimicrobial Susceptibility Testing. NCCLS document M2-A4. NCCLS, Wayne, PA, USA.
33. NCCLS (2002) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard. NCCLS document M31-A2. NCCLS, Wayne, PA, USA.
34. Ouabdesselam, S., Hooper, D.C., Tankovic, J. Soussy, C.J. (1995) Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrobial Agents and Chemotherapy, 39, 1667 1670.
35. Pan, X.S. Fisher, L.M. (1998) DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 42, 2810 2816.
36. Pan, X.S. Fisher, L.M. (1999) Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrobial Agents and Chemotherapy, 43, 1129 1136.
37. Peterson, L.R. (2001) Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity. Clinical Infectious Diseases, 15, S180 S186.
38. Robicsek, A., Jacoby, G.A. Hooper, D.C. (2006) The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infectious Diseases, 6, 629 640.
39. Ruiz, J. (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. Journal of Antimicrobial Chemotherapy, 51, 1109 1117.
40. Sambrook, J., Fritsch, E.F. Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, NY, USA.
41. Sanders, C.C. (2001) Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clinical Infectious Diseases, 32, S1 S8.
42. Sasaki, A., Shimizu, A., Kawano, J., Wakita, Y., Hayashi, T. Ootsuki, S. (2005) Characteristics of Staphylococcus intermedius isolates from diseased and healthy dogs. Journal of Veterinary Medical Science, 67, 103 106.
43. Sreedharan, S., Peterson, L.R. Fisher, L.M. (1991) Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy, 35, 2151 2154.
44. Weese, J.S., Dick, H., Willey, B.M., McGeer, A., Kreiswirth, B.N., Innis, B. D.E. Low, D.E. (2006) Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Veterinary Microbiology, 115, 148 155.
45. Werckenthin, C., Cardoso, M., Martel, J.L. Schwarz, S. (2001) Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius. Veterinary Research, 32, 341 362.
46. Yamagishi, J., Kojima, T., Oyamada, Y., Fujimoto, K., Hattori, H., Nakamura, S. Inoue, M. (1996) Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 40, 1157 1163.
47. Yamashita, K., Shimizu, A., Kawano, J., Uchida, E., Haruna, A. Igimi, S. (2005) Isolation and characterization of staphylococci from external auditory meatus of dogs with or without otitis externa with special reference to Staphylococcus schleiferi subsp. coagulans isolates. Journal of Veterinary Medical Science, 67, 263 268.